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Abstract
Background—Human papilloma virus (HPV) is the most common sexually transmitted 
infection (STI) globally, with a high burden of anogenital warts (AGW) among men who have sex 
with men (MSM) and transwomen (TW).
Methods—Six-hundred HIV negative MSM and TW (300 with AGW, 300 without) were 
recruited for a prospective cohort study to examine HPV outcomes and HPV vaccine knowledge. 
Participants completed a self-administered online questionnaire. Logistic regression was used to 
assess the association between sociodemographic and behavioral characteristics with HPV vaccine 
knowledge.
Results—The average participant age was 25.5 years. Most (67%) were single and 41.2% self-
reported STI symptoms. The average age of first anal intercourse was 17 years, with self-reported 
sexual role as active (36%), passive (36%), and both (27%). Three quarters (77%) of participants 
reported engaging in condomless anal or oral sex up to six months prior to the study. Less than 
half (48%) of participants had heard of HPV. Participants with AGW were more likely to report 
that condoms helped prevent HPV (p=0.01) and that the absence of genital warts does not mean 
the absence of HPV (p<0.01).
Conclusion—Study participants had low levels of HPV knowledge but likely high HPV 
exposure due to condomless anal sex. The HPV knowledge gap may be explained in part by the 
stigma of sex work, underreporting of STIs, the high cost of the HPV vaccine in Peru, and 
misinformation about HPV vaccine. More work is needed to educate MSM and TW on HPV and 
the HPV vaccine.
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Introduction
Human papilloma virus is the most common sexually transmitted infection (STI) in the US 
and the prevalence of HPV in men who have sex with men (MSM) in the US at any 
anatomical site is higher than the general population [1,2]. Despite the large body of work 
on other STIs and HIV in South America, little equivalent data on HPV are available [3]. 
Anecdotal reports from Peruvian sexual health clinics suggest a high burden of the clinical 
manifestation of HPV (genital warts) in the anal, perianal, and penile regions of MSM. At 
Epicentro, a community sexual health clinic with tailored services for MSM and trans 
women (TW) in Lima, HPV-related disease accounts for over thirty-five percent of all 
medical consultations received [personal communication from medical director Gino 
Calvo].
The disease burden of HPV in MSM and TW in Peru is obscured by the lack of knowledge 
regarding the interactions between HPV and HIV infection and stigma faced by individuals 
with genital warts [4]. This is especially troubling given that anal warts are a significant risk 
factor for anal squamous intraepithelial neoplasia and subsequent anal cancer in HIV-
infected men [5]. Studies have found that a recent history of receptive anal intercourse 
doubled the risk of HPV infection in MSM and the majority of new HIV infections in Latin 
America occur among MSM through anal sex [6,7]. In addition, the relationship between 
many other ulcerative genital STIs, such as herpes simplex virus type 2, syphilis, and 
chancroid are all known to enhance the transmission of HIV whereas the role of HPV and 
HPV-related disease is unknown [8, 9, 10].
This novel study measured the prevalence of anogenital warts (AGW) in MSM and TW 
presenting at a community clinic to determine their level of awareness of HPV and the HPV 
vaccine.
Materials and Methods
Participants
Six-hundred HIV-uninfected MSM and TW were recruited using venue-based sampling at 
Epicentro, a community-based men’s sexual health clinic in Lima, Peru, and other locations 
(bars, clubs, discotheques, volley ball courts) that MSM and TW frequent. Additionally, 
recruitment banners were placed on gay websites directing participants to call or visit 
Epicentro for a screening appointment. Inclusion criteria were age 18–40 years, ability to 
provide informed consent for study participation, residency in Lima, being HIV-uninfected, 
and self-reporting receptive anal sex in the past 12 months. Participation was further limited 
to those who had not participated in a HIV or HPV vaccine clinical trial, did not have a 
diagnosis with an immunodeficiency disease that increased the risk of AGW, and had not 
taken HIV pre-exposure prophylaxis. Potential participants were first screened for HIV 
using the Determine HIV-1/2 Ag/Ab Combo rapid test. HIV-infected participants were 
provided accompaniment to free HIV care and treatment. HIV negative persons were invited 
to participate in the study. We aimed to recruit equal numbers of participants reporting 
current/prior AGW (arm A) and those who had no history of AGW (arm B) and continued 
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recruitment until both arms reached 300. Rapid syphilis testing was conducted using rapid 
plasma reagin (RPR) titers and Treponema pallidum Particle Agglutination (TPPA) test and 
treatment followed national guidelines. Institutional Review Boards at the University of 
California, Los Angeles and Asociación Civil Impacta Salud y Educación in Lima, Peru 
reviewed and approved the study protocol, recruitment materials and informed consent 
forms. Full details of the study protocol have been published [11].
Data Collection
Participants completed a self-administered questionnaire consisting of 84 questions on 
demographics, history of STIs, sexuality and sexual behavior, HPV knowledge, drug and 
alcohol use, acceptability of oral HIV testing, and rectal douching. Knowledge of HPV was 
measured by a standard survey validated in previous studies [12, 13]. Upon completion of 
the questionnaire, participants were offered a gift worth US$2.00 as well as condoms and 
lubricant.
Data Analyses
Survey data was entered into SurveyMonkey Gold and checked for logic and range. Stata 
12.0 (Statacorp LP, College Station, Texas) was used for quantitative data analyses. Mean, 
ranges, standard deviation (SD), and percentages were reported for demographic data and 
variables describing participants in our study. Pearson’s chi-square and Fisher’s exact tests 
were computed for differences in HPV knowledge by AGW status.
Results
Study Population
The average age of the participants was 25.5 years. Most (67%) participants were single, had 
completed a tertiary or university education (53%), and were current smokers (54%). Nearly 
one third (30%) reported having sex under the influence of alcohol in the month before they 
completed the survey; 8.5% reported the same for drugs. 41.2% of participants self-reported 
STI symptoms and diagnoses; symptoms and diagnoses explicitly assessed in the survey 
included anal and genital lesions, genital ulcers, and syphilis. The average age of 
participants’ first anal intercourse was seventeen (SD = 4.58). 174 (29%) participants 
reported engaging in transactional sex, with an average age of first transactional sex at 18.5 
years (SD = 4.32).
Three quarters (77%) of participants reported engaging in some form of unprotected anal or 
oral sex six months prior to their participation in the survey. This 63% percent who reported 
either insertive (32%) or receptive (37%) condomless anal sex three months prior to 
completing the survey and 71% percent who reported having condomless oral sex in the 
same time period. A majority (81%) of participants who received money or favors for sex, 
reported having only male sex partners. Participants self-reported their sexual role as active 
(36%), passive (36%), and both (27%).
Participants with AGW were significantly more likely to be educated than peers without a 
history of AGW (OR = 2.41, CI = 1.74, 3.36) and to assume an active or equally active and 
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passive role during sex (OR = 1.61, CI = 1.15, 2.27). They were significantly less likely to 
have ever smoked (OR = 0.57, CI = 0.38, 0.86) or to have exchanged favors for sex in the 
six months prior to their participation in the survey (OR = 0.36, CI = 0.24, 0.52). Finally, 
participants with AGW were less likely to have used condoms during their last sexual 
encounter than those without AGW (OR = 0.44, CI = 0.31, 0.61)
HPV and HPV Vaccine Knowledge
Less than half (48%) of participants had heard of HPV before their participation in the 
study, and only 19% of participants reported knowing of HPV vaccine. Results were similar 
with regards to a vaccine to prevent anal cancer; with 11% of participants knowing of a 
vaccine and 60% of participants reported they would utilize such a vaccine if it were made 
available. Participants with AGW were more likely to report that condoms help prevent 
HPV (OR = 2.12, 95% CI= 1.13–4.01) and that the absence of genital warts does not mean 
the absence of HPV (OR = 1.64 95% CI=1.27–2.13). Those with AGW were also less likely 
to report the availability of a vaccine to prevent genital warts (OR = 0.3, 95% CI=0.15–
0.62).
Education level was a strong predictor of HPV and HPV vaccine knowledge. Participants 
with a tertiary education or beyond (including university) were more likely to correctly 
identify that condoms help prevent HPV (OR = 1.64, 95%CI = 1.-5, 2.59) and that the 
absence of genital warts does not mean the absence of HPV (OR = 9.52, 95% CI = 3.75–
24.19). Paradoxically, those with a higher education were less likely to report HPV vaccine 
knowledge (OR=2.86, 95%CI=1.39–5.92). In addition, participants who were having 
condomless sex and those who did not identify as gay were significantly more likely to 
answer correctly with regards to the availability of a vaccine that prevents genital warts (p = 
0.04 and p = 0.01, respectively). TW participants (34.8%) were four times as likely 
compared to other participants (7.7%) to respond that a lack of genital warts meant that HPV 
infection had also been resolved.
Discussion
Study participants had low levels of knowledge of HPV and HPV vaccines but likely high 
HPV exposure due to frequency of condomless anal sex and participation in the sex trade. 
Of note, participants with a higher education were more likely to have current or a history of 
AGW and less likely to be knowledgeable about HPV vaccines than those with a lower 
education. Paradoxically, these same participants were more likely to answer other questions 
about sexual health correctly, including whether condoms help prevent the spread of HPV. 
This knowledge gap may be explained in part by barriers cited in previous research, such as 
the stigma of sex work, underreporting of STIs, the high cost of the vaccine in Peru, and 
misinformation and fear about what the vaccine is and if it works [12].
HPV related knowledge was collected in a previous study of female sex workers (FSWs) in 
Lima. Compared to FSWs, participants in our study were less likely to report that condoms 
help prevent HPV transmission and less desirous of an HPV vaccine. Registered FSWs must 
visit a special clinic to obtain their health card, which serves as a license to conduct sex 
work [12]. Though this does not guarantee sexual health education, it provides an 
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opportunity to seek it, especially when compared to MSM and TW, who are often excluded 
from such services. More than half of participants in our study reported wanting to receive 
HPV vaccine. In a similar study in China, the majority of participants in the same age group 
as our study reported they were interested in being vaccinated [14]. This difference likely 
arises from many factors, including cultural norms and the barriers, differential access to 
sexual health knowledge, and acceptability of being vaccinated. Undoubtedly, important 
knowledge gaps remain with regards to HPV and HPV vaccine which must be addressed 
through culturally-competent education programs. This includes ensuring that local health 
professionals and laypersons in Lima become well-informed about HPV vaccine. At present 
we are not aware of national education campaigns about HPV vaccine in Peru for girls or 
boys.
There were several limitations in our study. The majority of our questions were closed-
ended, and it is possible that open-ended questions with probes may have better gauged 
HPV knowledge. This limitation is compounded by the fact that our survey relied on 
participant recall, which may be subject to recall bias. In addition, our results may not be 
generalizable to MSM or TW outside Lima due to the convenience and clinic-based 
sampling method used. Finally, though TW face disproportionate STI burden throughout 
Latin America, even when compared to MSM [15], they represented only a fraction of 
respondents (11.5%). Special efforts must be made to be inclusive of TW in population-
based STI research.
All men and women should have access to HPV vaccines and be targeted for education 
campaigns to gain HPV related knowledge and overcome the barriers they would face in 
vaccine campaigns. It also serves to call attention to the need for additional research among 
MSM and TW from Peru. These groups face a disproportionate disease risk and burden 
because of the social stigma they face, the difficulty in finding culturally-competent 
services, and the cost of relevant treatments. Additional studies are needed in MSM and TW 
to determine the potential cost-effectiveness of the vaccine in HPV-exposed populations.
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Table 1
Characteristics of 600 MSM and Trans Women in Lima, Peru by visible anogenital wart (AGW) status
Criteria: ALL PARTICIPANTS
N (%)
No Visible AGW 
(N=377)
N (%)
Visible AGW (N=223)
N (%)
P-value
AGE, years
 <20 124 (20.6) 65 (17.2) 59 (26.5) 0.05
 20–25 227 (37.8) 144 (38.2) 83 (37.2)
 26–30 134 (22.3) 91 (24.1) 43 (19.3)
 31–35 69 (11.5) 49 (13.0) 20 (9.0)
 36–40 46 (7.7) 28(7.4) 18 (8.1)
EDUCATION
 Primary 19 (3.2) 12 (3.2) 7 (3.1) 0.002
 Secondary 264 (44.0) 188 (49.9) 76 (34.1)
 College (No Degree) 132 (22.0) 71 (18.8) 61 (27.4)
 College (Degree) 185 (30.8) 106 (28.1) 79 (35.4)
EVER SMOKED
 No 118 (20.1) 60 (16.4) 58 (26.2) 0.004
 Yes 470 (79.9) 307 (83.7) 163 (73.8)
SEX ROLE
 Active/Mostly Active 212 (36.4) 129(35.3) 83 (38.1) 0.009
 Equal 160 (27.4) 88 (24.1) 72 (33.0)
 Passive/Mostly Passive 211 (36.2) 148 (40.6) 63 (28.9)
SEX PARTNERS
 Mostly/Only Women 56 (9.4) 39 (10.5) 17 (7.7) 0.42
 Equal 40 (6.8) 27 (7.2) 13 (5.9)
 Mostly/Only Men 497 (83.8) 307 (82.3) 190 (86.4)
CONDOMLESS SEX
 No 137 (23.1) 76 (20.5) 61 (27.5) 0.002
 Anal OR Oral Sex 290 (48.9) 173 (46.6) 117 (52.7)
 Both 166 (28) 122 (32.9) 44 (19.8)
AGE OF 1st ANAL SEX
 < 14 110 (18.3) 82 (21.8) 28 (12.6) 0.007
 14–19 356 (59.3) 221 (58.6) 135 (60.5)
 >19 134 (22.3) 74 (19.6) 60 (26.9)
AGE OF 1st ORAL SEX ON A MAN
 < 11 38 (7.8) 26 (8.6) 12 (6.5) 0.09
 11–17 238 (48.7) 159 (52.3) 79 (42.7)
 18–25 186 (38) 104 (34.2) 82 (44.3)
 > 25 27 (5.5) 15 (4.9) 12 (6.5)
AGE 1ST TRANSACTIONAL SEX
 < 14 11 (6.3) 6 (4.5) 5 (12.5) 0.15*
 14–19 109 (62.6) 84 (62.7) 23 (62.5)
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Criteria: ALL PARTICIPANTS
N (%)
No Visible AGW 
(N=377)
N (%)
Visible AGW (N=223)
N (%)
P-value
 > 19 54 (31.0) 44 (32.8) 10 (25.0)
IDENTITY
 Gay 284 (47.9) 162(43.6) 122 (55.0) 0.003
 Bi 156 (26.3) 98(26.4) 58 (26.1)
 Trans/Woman/Other 96 (16.2) 75 (20.2) 21 (9.5)
 Straight 57 (9.6) 36 (9.7) 21 (9.5)
PAST 6 MONTHS: RECEIVED MONEY/
FAVORS FOR SEX?
 No 408 (70.1) 227 (62.9) 181 (81.9) < 0.001
 Yes 174 (29.9) 134 (37.1) 40 (18.1)
CURRENT PARTNER WITH AGW**
 No 138 (72.6) 91 (90.10) 47 (78.3) 0.04
 Yes 23 (12.1) 10 (9.9) 13 (21.7)
WERE CONDOMS USED WITH LAST 
PARTNER?
 No 366 (61.0) 208 (55.2) 158 (70.9) < 0.001
 Yes 234 (39.0) 169 (44.8) 65 (29.2)
*
Fisher’s Exact Test used
**
This question was analyzed only among those who reported having a partner
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